Brain implant delivers ultrasonic waves to brain treating cancer, Alzheimer’s

A recent study published in Advanced Healthcare Materials outlines a new ceramic skull implant capable of delivering ultrasound treatments.

Ultrasonic waves can treat many types of brain diseases like Alzheimer’s and Parkinson’s. They can also be used to combat brain cancer and dissolve blood clots following stroke. These waves, while showing such potential, remain unable to pass through the two to eight mm thick skull wall.

Led by Guillermo Aguilar, professor and chair of mechanical engineering in University of California, Riverside's Bourns College of Engineering, and Javier E. Garay, professor of mechanical and aerospace engineering in UC San Diego's Jacobs School of Engineering, the team developed a ceramic implant that allows for ultrasound to pass into the brain. The biocompatible and shatter-proof material makes the implant viable and safe for implantation. In testing, physicians were able to deliver therapeutic sound waves to the brain both on demand and in a routine.

"These materials are already being used in dental crowns and hip replacements, and our team is working to extend their application to the diagnosis and treatment of a wide variety of brain pathologies and neurological disorders," Aguilar said. "Developing an optically and radio-frequency transparent cranial implant was already an exciting accomplishment, and we continue to work to make this implant a reality. Now, proving that ultrasound could be transmitted through the implant could expand its therapeutic capabilities even further."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup